{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:06:23Z","timestamp":1785305183601,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10741-020-10051-z","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T04:55:37Z","timestamp":1604984137000},"page":"531-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of atrial fibrillation on the outcomes of transcatheter mitral valve repair using MitraClip: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8702-3026","authenticated-orcid":false,"given":"Siddharth","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Abdelghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Mena-Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanik","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"issue":"25","key":"10051_CR1","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","volume":"135","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O\u2019Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A (2017) 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation 135(25):e1159\u2013e1195. https:\/\/doi.org\/10.1161\/CIR.0000000000000503","journal-title":"Circulation"},{"issue":"15","key":"10051_CR2","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","volume":"364","author":"T Feldman","year":"2011","unstructured":"Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L, Investigators EI (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364(15):1395\u20131406. https:\/\/doi.org\/10.1056\/NEJMoa1009355","journal-title":"N Engl J Med"},{"issue":"24","key":"10051_CR3","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ, Investigators C (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379(24):2307\u20132318. https:\/\/doi.org\/10.1056\/NEJMoa1806640","journal-title":"N Engl J Med"},{"issue":"17","key":"10051_CR4","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.jacc.2020.02.005","volume":"75","author":"RO Bonow","year":"2020","unstructured":"Bonow RO, O\u2019Gara PT, Adams DH, Badhwar V, Bavaria JE, Elmariah S, Hung JW, Lindenfeld J, Morris AA, Satpathy R, Whisenant B, Woo YJ (2020) 2020 focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 75(17):2236\u20132270. https:\/\/doi.org\/10.1016\/j.jacc.2020.02.005","journal-title":"J Am Coll Cardiol"},{"key":"10051_CR5","doi-asserted-by":"publisher","unstructured":"Kessler M, Pott A, Mammadova E, Seeger J, Wohrle J, Rottbauer W, Markovic S (2018) Atrial fibrillation predicts long-term outcome after transcatheter edge-to-edge mitral valve repair by MitraClip implantation. Biomolecules 8(4). https:\/\/doi.org\/10.3390\/biom8040152","DOI":"10.3390\/biom8040152"},{"issue":"1","key":"10051_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/s0735-1097(02)01922-8","volume":"40","author":"F Grigioni","year":"2002","unstructured":"Grigioni F, Avierinos JF, Ling LH, Scott CG, Bailey KR, Tajik AJ, Frye RL, Enriquez-Sarano M (2002) Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 40(1):84\u201392. https:\/\/doi.org\/10.1016\/s0735-1097(02)01922-8","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10051_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ejcts.2006.12.039","volume":"31","author":"C Alexiou","year":"2007","unstructured":"Alexiou C, Doukas G, Oc M, Oc B, Swanevelder J, Samani NJ, Spyt TJ (2007) The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation. Eur J Cardiothorac Surg 31(4):586\u2013591. https:\/\/doi.org\/10.1016\/j.ejcts.2006.12.039","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12 Suppl 1","key":"10051_CR8","doi-asserted-by":"publisher","first-page":"I59","DOI":"10.1161\/hc37t1.094813","volume":"104","author":"E Lim","year":"2001","unstructured":"Lim E, Barlow CW, Hosseinpour AR, Wisbey C, Wilson K, Pidgeon W, Charman S, Barlow JB, Wells FC (2001) Influence of atrial fibrillation on outcome following mitral valve repair. Circulation 104(12 Suppl 1):I59\u2013I63. https:\/\/doi.org\/10.1161\/hc37t1.094813","journal-title":"Circulation"},{"issue":"2","key":"10051_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0022-5223(12)70085-5","volume":"107","author":"YL Chua","year":"1994","unstructured":"Chua YL, Schaff HV, Orszulak TA, Morris JJ (1994) Outcome of mitral valve repair in patients with preoperative atrial fibrillation. Should the maze procedure be combined with mitral valvuloplasty? J Thorac Cardiovasc Surg 107(2):408\u2013415","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10051_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269, W264. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"issue":"3","key":"10051_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"key":"10051_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135","journal-title":"BMC Med Res Methodol"},{"key":"10051_CR13","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods G, Cochrane Statistical Methods G (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"issue":"4","key":"10051_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, Rucker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22(4):153\u2013160. https:\/\/doi.org\/10.1136\/ebmental-2019-300117","journal-title":"Evid Based Ment Health"},{"key":"10051_CR15","doi-asserted-by":"publisher","unstructured":"Giordano A (2015) History of paroxysmal, persistent, long-standing or permanent atrial fibrillation in patients undergoing transcatheter mitral valve repair with Mitraclip: Does it Matter? J Clin Trials Cardiol 2(1). https:\/\/doi.org\/10.15226\/2374-6882\/2\/1\/00117","DOI":"10.15226\/2374-6882\/2\/1\/00117"},{"issue":"14","key":"10051_CR16","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jacc.2011.12.023","volume":"59","author":"HC Herrmann","year":"2012","unstructured":"Herrmann HC, Gertz ZM, Silvestry FE, Wiegers SE, Woo YJ, Hermiller J, Segar D, Heimansohn D, Gray W, Homma S, Argenziano M, Wang A, Jollis J, Lampert MB, Alexander J, Mauri L, Foster E, Glower D, Feldman T (2012) Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. J Am Coll Cardiol 59(14):1312\u20131319. https:\/\/doi.org\/10.1016\/j.jacc.2011.12.023","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10051_CR17","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.4244\/EIJ-D-16-00115","volume":"12","author":"A Jabs","year":"2017","unstructured":"Jabs A, von Bardeleben RS, Boekstegers P, Puls M, Lubos E, Bekeredjian R, Ouarrak T, Plicht B, Eggebrecht H, Nickenig G, Butter C, Hoffmann R, Senges J, Hink U (2017) Effects of atrial fibrillation and heart rate on percutaneous mitral valve repair with MitraClip: results from the TRAnscatheter Mitral valve Interventions (TRAMI) registry. EuroIntervention 12(14):1697\u20131705. https:\/\/doi.org\/10.4244\/EIJ-D-16-00115","journal-title":"EuroIntervention"},{"issue":"8","key":"10051_CR18","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.amjcard.2018.06.050","volume":"122","author":"M Spieker","year":"2018","unstructured":"Spieker M, Hellhammer K, Spiesshofer J, Katsianos S, Balzer J, Zeus T, Horn P, Kelm M, Westenfeld R (2018) Effect of atrial fibrillation and mitral valve gradients on response to percutaneous mitral valve repair with the MitraClip system. Am J Cardiol 122(8):1371\u20131378. https:\/\/doi.org\/10.1016\/j.amjcard.2018.06.050","journal-title":"Am J Cardiol"},{"issue":"11","key":"10051_CR19","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.amjcard.2017.08.022","volume":"120","author":"JF Velu","year":"2017","unstructured":"Velu JF, Kortlandt FA, Hendriks T, Schurer RAJ, van Boven AJ, Koch KT, Vis MM, Henriques JP, Piek JJ, Van den Branden BJL, Schaap J, Rensing BJ, Swaans MJ, Bouma BJ, Van der Heyden JAS, Baan J Jr (2017) Comparison of outcome after percutaneous mitral valve repair with the MitraClip in patients with versus without atrial fibrillation. Am J Cardiol 120(11):2035\u20132040. https:\/\/doi.org\/10.1016\/j.amjcard.2017.08.022","journal-title":"Am J Cardiol"},{"issue":"6","key":"10051_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jcin.2018.12.012","volume":"12","author":"S Arora","year":"2019","unstructured":"Arora S, Vemulapalli S, Stebbins A, Ramm CJ, Kosinski AS, Sorajja P, Piccini JP, Cavender MA, Vavalle JP (2019) The prevalence and impact of atrial fibrillation on 1-year outcomes in patients undergoing transcatheter mitral valve repair: results from the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Valve Therapy Registry. JACC Cardiovasc Interv 12(6):569\u2013578. https:\/\/doi.org\/10.1016\/j.jcin.2018.12.012","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"10051_CR21","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/eurheartj\/ehi272","volume":"26","author":"K Eguchi","year":"2005","unstructured":"Eguchi K, Ohtaki E, Matsumura T, Tanaka K, Tohbaru T, Iguchi N, Misu K, Asano R, Nagayama M, Sumiyoshi T, Kasegawa H, Hosoda S (2005) Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation. Eur Heart J 26(18):1866\u20131872. https:\/\/doi.org\/10.1093\/eurheartj\/ehi272","journal-title":"Eur Heart J"},{"issue":"10","key":"10051_CR22","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jacc.2005.07.040","volume":"46","author":"MK Chung","year":"2005","unstructured":"Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, Kim SG, Martin LW, Rosenberg Y, Wyse DG, Investigators A (2005) Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) functional status substudy. J Am Coll Cardiol 46(10):1891\u20131899. https:\/\/doi.org\/10.1016\/j.jacc.2005.07.040","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10051_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1056\/NEJMcp003331","volume":"345","author":"CM Otto","year":"2001","unstructured":"Otto CM (2001) Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med 345(10):740\u2013746. https:\/\/doi.org\/10.1056\/NEJMcp003331","journal-title":"N Engl J Med"},{"issue":"1","key":"10051_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jchf.2016.09.016","volume":"5","author":"A Pandey","year":"2017","unstructured":"Pandey A, Kim S, Moore C, Thomas L, Gersh B, Allen LA, Kowey PR, Mahaffey KW, Hylek E, Peterson ED, Piccini JP, Fonarow GC, Investigators O-A, Patients (2017) Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation. JACC Heart Fail 5(1):44\u201352. https:\/\/doi.org\/10.1016\/j.jchf.2016.09.016","journal-title":"JACC Heart Fail"},{"issue":"20","key":"10051_CR25","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","volume":"37","author":"AN Ganesan","year":"2016","unstructured":"Ganesan AN, Chew DP, Hartshorne T, Selvanayagam JB, Aylward PE, Sanders P, McGavigan AD (2016) The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J 37(20):1591\u20131602. https:\/\/doi.org\/10.1093\/eurheartj\/ehw007","journal-title":"Eur Heart J"},{"issue":"5","key":"10051_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","volume":"36","author":"BA Steinberg","year":"2015","unstructured":"Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, Becker RC, Singer DE, Halperin JL, Hacke W, Nessel CC, Berkowitz SD, Mahaffey KW, Fox KA, Califf RM, Piccini JP, Committee R-AS, Investigators (2015) Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J 36(5):288\u2013296. https:\/\/doi.org\/10.1093\/eurheartj\/ehu359","journal-title":"Eur Heart J"},{"issue":"31","key":"10051_CR27","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","volume":"34","author":"SM Al-Khatib","year":"2013","unstructured":"Al-Khatib SM, Thomas L, Wallentin L, Lopes RD, Gersh B, Garcia D, Ezekowitz J, Alings M, Yang H, Alexander JH, Flaker G, Hanna M, Granger CB (2013) Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J 34(31):2464\u20132471. https:\/\/doi.org\/10.1093\/eurheartj\/eht135","journal-title":"Eur Heart J"},{"key":"10051_CR28","doi-asserted-by":"publisher","unstructured":"Link MS, Giugliano RP, Ruff CT, Scirica BM, Huikuri H, Oto A, Crompton AE, Murphy SA, Lanz H, Mercuri MF, Antman EM, Braunwald E, Investigators EA-T (2017) Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circ Arrhythm Electrophysiol 10(1). https:\/\/doi.org\/10.1161\/CIRCEP.116.004267","DOI":"10.1161\/CIRCEP.116.004267"},{"issue":"2","key":"10051_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jacc.2003.08.037","volume":"43","author":"VE Hagens","year":"2004","unstructured":"Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC, Group RS (2004) Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol 43(2):241\u2013247. https:\/\/doi.org\/10.1016\/j.jacc.2003.08.037","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10051_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/hrt.2008.158931","volume":"95","author":"RJ Shelton","year":"2009","unstructured":"Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG (2009) A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study). Heart 95(11):924\u2013930. https:\/\/doi.org\/10.1136\/hrt.2008.158931","journal-title":"Heart"},{"issue":"10","key":"10051_CR31","doi-asserted-by":"publisher","first-page":"e009317","DOI":"10.1161\/CIRCIMAGING.119.009317","volume":"12","author":"S Nishino","year":"2019","unstructured":"Nishino S, Watanabe N, Ashikaga K, Morihisa K, Kuriyama N, Asada Y, Shibata Y (2019) Reverse remodeling of the mitral valve complex after radiofrequency catheter ablation for atrial fibrillation: a serial 3-dimensional echocardiographic study. Circ Cardiovasc Imaging 12(10):e009317. https:\/\/doi.org\/10.1161\/CIRCIMAGING.119.009317","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"10051_CR32","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/jce.13964","volume":"30","author":"L Rottner","year":"2019","unstructured":"Rottner L, Lemes C, Dotz I, Wohlmuth P, Schmidt T, Mathew S, Heeger CH, Reissmann B, Fink T, Rillig A, Frerker C, Ouyang F, Kuck KH, Metzner A, Maurer T (2019) The clip and the tip: lessons learned from ablation of atrial fibrillation in patients postpercutaneous mitral valve repair. J Cardiovasc Electrophysiol 30(8):1207\u20131214. https:\/\/doi.org\/10.1111\/jce.13964","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7\u20138","key":"10051_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.repc.2016.11.012","volume":"36","author":"ARG Francisco","year":"2017","unstructured":"Francisco ARG, Infante de Oliveira E, Nobre Menezes M, Carrilho Ferreira P, Canas da Silva P, Nobre A, Pinto FJ (2017) Combined MitraClip implantation and left atrial appendage occlusion using the watchman device: a case series from a referral center. Rev Port Cardiol 36(7\u20138):525\u2013532. https:\/\/doi.org\/10.1016\/j.repc.2016.11.012","journal-title":"Rev Port Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10051-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-020-10051-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10051-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T06:11:00Z","timestamp":1617689460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-020-10051-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10051"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-10051-z","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"27 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mahmoud Abdelghany, MD, is a speaker and consultant for Abbott Vascular. Carlos Mena-Hurtado, MD, is a consultant for Abbott Vascular, COOK, Medtronic, Cardinal Health, Boston Scientific, and Optum Labs. Siddharth Shah, MD, has no conflict of interest to declare. Vijay Raj, MD, has no conflict of interest to declare. Sana Riaz has no conflict of interest to declare. Siddharth Patel, MBBS, MPH, has no conflict of interest to declare. Howard Wiener, PhD, has no conflict of interest to declare. Debanik Chaudhuri, MD, has no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Available upon request","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}